Type 1 diabetes |
-
•
LIPS diagnostic performance matched a gold standard radioactive-binding assay for the detection of IA2, IA2-β, and GAD65 autoantibodies11, 12
-
•
Detected high frequency of autoantibodies against other autoimmune targets in patients with type 1 diabetes for potentially identifying patient subsets19
|
Immunodysregulation, polyendocrinopathy, enteropathy X-linked syndrome |
|
Stiff person syndrome |
|
SS |
-
•
LIPS showed 75% sensitivity for the detection of SSB autoantibodies compared with 45% sensitivity for an enzyme-linked immunosorbent assay24
-
•
Detected 16% frequency of autoantibodies against gastric adenosine triphosphatase in patients with SS24
-
•
Sensitive detection of Ro60 and Ro52 autoantibodies for diagnosis in the saliva of patients with SS25
|
SLE |
|
Patients with thymoma |
-
•
Identified a subset of patients with thymoma with multiple anticytokine autoantibodies, which correlated with opportunistic infections in patients34
-
•
Relative levels of anticytokine autoantibodies detected by LIPS correlated with in vitro neutralizing activity34
|
dNTM |
|
ARDS and sepsis |
|